Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-24T23:04:37.270Z Has data issue: false hasContentIssue false
  • English
  • Français

Dimensions of improvement in a clinical trial of N-acetyl cysteine for bipolar disorder

Published online by Cambridge University Press:  24 June 2014

Pedro V. Magalhães ,
Olivia M. Dean ,
Ashley I. Bush ,
David L. Copolov ,
Gin S. Malhi ,
Kristy Kohlmann ,
Susan Jeavons ,
Ian Schapkaitz ,
Murray Anderson-Hunt  and
Michael Berk
Pedro V. Magalhães
Affiliation:
National Institute for Translational Medicine, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil Department of Clinical and Biomedical Sciences: Barwon Health, The University of Melbourne, Geelong, Australia
Olivia M. Dean
Affiliation:
Department of Clinical and Biomedical Sciences: Barwon Health, The University of Melbourne, Geelong, Australia Mental Health Research Institute of Victoria, Parkville, Victoria, Australia
Ashley I. Bush
Affiliation:
Department of Clinical and Biomedical Sciences: Barwon Health, The University of Melbourne, Geelong, Australia
David L. Copolov
Affiliation:
Office of the Vice-Chancellor & President, Monash University, Clayton, Victoria, Australia
Gin S. Malhi
Affiliation:
Discipline of Psychiatry, Sydney Medical School, University of Sydney, Sydney, Australia CADE Clinic, Department of Psychiatry, Royal North Shore Hospital, Sydney, Australia
Kristy Kohlmann
Affiliation:
Department of Clinical and Biomedical Sciences: Barwon Health, The University of Melbourne, Geelong, Australia Mental Health Research Institute of Victoria, Parkville, Victoria, Australia
Susan Jeavons
Affiliation:
Department of Clinical and Biomedical Sciences: Barwon Health, The University of Melbourne, Geelong, Australia School of Psychological Science, La Trobe University – Bendigo Campus, Bendigo, Australia
Ian Schapkaitz
Affiliation:
Department of Clinical and Biomedical Sciences: Barwon Health, The University of Melbourne, Geelong, Australia
Murray Anderson-Hunt
Affiliation:
Department of Clinical and Biomedical Sciences: Barwon Health, The University of Melbourne, Geelong, Australia
Michael Berk
Affiliation:
Department of Clinical and Biomedical Sciences: Barwon Health, The University of Melbourne, Geelong, Australia Mental Health Research Institute of Victoria, Parkville, Victoria, Australia
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Comment & Critique
Information
Acta Neuropsychiatrica , Volume 23 , Issue 2 , April 2011 , pp. 87 - 88
Copyright
Copyright © Cambridge University Press 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Michalak, EE, Yatham, LN, Kolesar, S, Lam, RW.Bipolar disorder and quality of life: a patient-centered perspective. Qual Life Res 2006;15:25–37.CrossRefGoogle ScholarPubMed
2.Gazalle, FK, Andreazza, AC, Hallal, PC et al. Bipolar depression: the importance of being on remission. Rev Bras Psiqui 2006;28:93–96.CrossRefGoogle ScholarPubMed
3.Gazalle, FK, Hallal, PC, Andreazza, AC et al. Manic symptoms and quality of life in bipolar disorder. Psychiat Res 2007;153:33–38.CrossRefGoogle ScholarPubMed
4.Fabrigar, LR, Wegener, DT, MacCallum, RC, Strahan, EJ.Evaluating the use of exploratory factor analysis in psychological research. Psychol Methods 1999;4:272–299.CrossRefGoogle Scholar
5.Sanchez-Moreno, J, Martinez-Aran, A, Tabares-Seisdedos, R, Torrent, C, Vieta, E, Ayuso-Mateos, JL.Functioning and disability in bipolar disorder: an extensive review. Psychother Psychosom 2009;78:285–297.CrossRefGoogle ScholarPubMed
6.Berk, M, Copolov, DL, Dean, O et al. N-acetyl cysteine for depressive symptoms in bipolar disorder – a double-blind randomized placebo-controlled trial. Biol Psychiatry 2008;64:468–475.CrossRefGoogle ScholarPubMed
7.Montgomery, SA, Asberg, M.New depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382–389.CrossRefGoogle ScholarPubMed
8.Young, RC, Biggs, JT, Ziegler, VE, Meyer, DA.Rating-scale for mania – reliability, validity and sensitivity. Br J Psychiatry 1978;133:429–435.CrossRefGoogle ScholarPubMed
9.Berk, M, Malhi, GS, Mitchell, PB et al. Scale matters: the need for a Bipolar Depression Rating Scale (BDRS). Acta Psychiatr Scand 2004;110:39–45.CrossRefGoogle Scholar
10.Berk, M, Malhi, GS, Cahill, C et al. The bipolar depression rating scale (BDRS): its development, validation and utility. Bipolar Disord 2007;9:571–579.CrossRefGoogle ScholarPubMed
11.Jones, SH, Thornicroft, G, Coffey, M, Dunn, G.A brief mental-health outcome scale – reliability and validity of the global assessment of functioning (GAF). Br J Psychiat 1995;166:654–659.CrossRefGoogle ScholarPubMed
12.Morosini, PL, Magliano, L, Brambilla, L, Ugolini, S, Pioli, R.Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social funtioning. Acta Psych Scand 2000;101:323–329.Google Scholar
13.Keller, MB, Lavori, PW, Friedman, B et al. The longitudinal interval follow-up evaluation – a comprehensive method for assessing outcome in prospective longitudinal-studies. Arch Gen Psychiatr 1987;44:540–548.CrossRefGoogle ScholarPubMed
14.Endicott, J, Nee, J, Harrison, W, Blumenthal, R.Quality-of-life enjoyment and satisfaction questionnaire – a new measure. Psychopharmacol Bull 1993;29:321–326.Google ScholarPubMed
15.Preacher, KJ, Hayes, AF.SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behav Res Methods Instrum Comp 2004;36:717–731.CrossRefGoogle ScholarPubMed
16.Brieger, P, Rottig, S, Rottig, D, Marneros, A, Priebe, S.Dimensions underlying outcome criteria in bipolar I disorder. J Affect Disord 2007;99:1–7.CrossRefGoogle ScholarPubMed
17.Giglio, LM, Magalhaes, PVS, Kapczinski, NS, Walz, JC, Kapczinski, F.Functional impact of biological rhythm disturbance in bipolar disorder. J Psychiatr Res 2010;44:220–223.CrossRefGoogle ScholarPubMed